Abstract
Nonspecific effects triggered by small interfering RNAs (siRNAs) complicate the use of RNA interference (RNAi) to specifically downregulate gene expression1,2,3,4,5. To uncover the basis of these nonspecific activities, we analyzed the effect of chemically synthesized siRNAs on mammalian double-stranded RNA (dsRNA)-activated signaling pathways. siRNAs ranging from 21 to 27 nucleotides (nt) in length activated the interferon system when they lacked 2-nt 3′ overhangs, a characteristic of Dicer products. We show that the recognition of siRNAs is mediated by the RNA helicase RIG-I and that the presence of 3′ overhangs impairs its ability to unwind the dsRNA substrate and activate downstream signaling to the transcription factor IRF-3. These results suggest a structural basis for discrimination between microRNAs that are endogenous Dicer products, and nonself dsRNAs such as by-products of viral replication. These findings will enable the rational design of siRNAs that avoid nonspecific effects or, alternatively, that induce bystander effects to potentially increase the efficacy of siRNA-based treatments of viral infections or cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Marques, J.T. & Williams, B.R. Activation of the mammalian immune system by siRNAs. Nat. Biotechnol. 23, 1399–1405 (2005).
Sledz, C.A., Holko, M., de Veer, M.J., Silverman, R.H. & Williams, B.R. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5, 834–839 (2003).
Kim, D.H. et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 22, 321–325 (2004).
Kariko, K., Bhuyan, P., Capodici, J. & Weissman, D. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J. Immunol. 172, 6545–6549 (2004).
Persengiev, S.P., Zhu, X. & Green, M.R. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10, 12–18 (2004).
Kim, D.H. et al. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23, 222–226 (2005).
Peters, K.L., Smith, H.L., Stark, G.R. & Sen, G.C. IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA. Proc. Natl. Acad. Sci. USA 99, 6322–6327 (2002).
Hornung, V. et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11, 263–270 (2005).
Judge, A.D. et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23, 457–462 (2005).
Ishii, K.J. et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7, 40–48 (2006).
Stetson, D.B. & Medzhitov, R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24, 93–103 (2006).
Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730–737 (2004).
Kato, H. et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23, 19–28 (2005).
Tanner, N.K. & Linder, P. DExD/H box RNA helicases: from generic motors to specific dissociation functions. Mol. Cell 8, 251–262 (2001).
Czauderna, F. et al. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 31, 2705–2716 (2003).
Siolas, D. et al. Synthetic shRNAs as potent RNAi triggers. Nat. Biotechnol. 23, 227–231 (2005).
Rose, S.D. et al. Functional polarity is introduced by Dicer processing of short substrate RNAs. Nucleic Acids Res. 33, 4140–4156 (2005).
Cullen, B.R. Transcription and processing of human microRNA precursors. Mol. Cell 16, 861–865 (2004).
Marques, J.T. et al. Down-regulation of p53 by double-stranded RNA modulates the antiviral response. J. Virol. 79, 11105–11114 (2005).
Ambros, V. The functions of animal microRNAs. Nature 431, 350–355 (2004).
Elbashir, S.M., Lendeckel, W. & Tuschl, T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15, 188–200 (2001).
Elbashir, S.M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498 (2001).
Caplen, N.J., Parrish, S., Imani, F., Fire, A. & Morgan, R.A. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA 98, 9742–9747 (2001).
Manche, L., Green, S.R., Schmedt, C. & Mathews, M.B. Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol. Cell. Biol. 12, 5238–5248 (1992).
Levy, D.E. & Marie, I.J. RIGging an antiviral defense–it's in the CARDs. Nat. Immunol. 5, 699–701 (2004).
Zhang, W. et al. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat. Med. 11, 56–62 (2005).
Palliser, D. et al. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439, 89–94 (2006).
Carpick, B.W. et al. Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I trans-activating region RNA. J. Biol. Chem. 272, 9510–9516 (1997).
Acknowledgements
We would like to thank Patricia Stanhope-Baker, Michelle Holko, Anthony Sadler and Mark Whitmore for helpful comments and Patricia Kessler and Scott D. Rose for valuable assistance. We are also grateful to Michael Gale Jr. for providing the sequences for DDX58 primers, James Finke and Patricia Rayman, Joe DiDonato and the DiDonato laboratory, Ganes Sen and the Sen laboratory and Yan Xu for providing reagents. This work was supported by National Institutes of Health grants RO1 AI34039 and PO1 CA 62220.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.A.B. is employed by Integrated DNA Technologies Inc. (IDT), which offers oligonucleotides for sale similar to the ones described in the manuscript. IDT is not, however, a publicly traded company and the author does not own any equity in IDT.
Supplementary information
Supplementary Fig. 1
The recognition of siRNAs containing blunt ends is TLR independent. (PDF 435 kb)
Supplementary Fig. 2
Chemically synthesized siRNAs with poor quality control can induce the activation of dsRNA signaling independently of size and structure. (PDF 706 kb)
Supplementary Fig. 3
Silencing RIG-I expression using siRNAs. (PDF 583 kb)
Supplementary Fig. 4
In vitro binding and activation of purified PKR by chemically synthesized siRNAs is independent of size or structure. (PDF 391 kb)
Supplementary Table 1
siRNAs targeting GFP (PDF 53 kb)
Supplementary Table 2
siRNAs targeting STAT1 (PDF 37 kb)
Supplementary Table 3
Mass spectrometry and HPLC analysis of siRNAs (PDF 51 kb)
Rights and permissions
About this article
Cite this article
Marques, J., Devosse, T., Wang, D. et al. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol 24, 559–565 (2006). https://doi.org/10.1038/nbt1205
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1205
This article is cited by
-
Mechanisms of length-dependent recognition of viral double-stranded RNA by RIG-I
Scientific Reports (2023)
-
Innate immune regulations and various siRNA modalities
Drug Delivery and Translational Research (2023)
-
Noncoding RNA therapeutics — challenges and potential solutions
Nature Reviews Drug Discovery (2021)
-
Constitutive immune mechanisms: mediators of host defence and immune regulation
Nature Reviews Immunology (2021)
-
Adenosine-to-inosine RNA editing in the immune system: friend or foe?
Cellular and Molecular Life Sciences (2020)